Cupid Ltd Q3 FY24 Share Price & Earnings Call Analysis

99out of 100

Momentum score · price trend

99 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,874 stocks
Last 12 months+619.1%100%
Last 6 months+257.0%99%
Last 3 months+62.7%97%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,874 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Cupid Ltd: 0.4 × 100 + 0.4 × 99 + 0.2 × 97 = 99.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 1 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Cupid Ltd announcements

All announcements →

Financials of Cupid Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Cupid Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +4235364066444751616590104132
Expenses +31322928323231354343565982
Operating Profit113712341216161821344550
OPM %26%9%20%30%51%26%34%31%30%33%38%43%38%
Other Income +2001000000000
Interest1000101011111
Depreciation1111111111111
Profit before tax112612321114141620324347
Tax %25%3%20%24%26%22%29%21%28%23%25%24%24%
Net Profit +825924810111215243336
EPS in Rs0.060.020.040.070.180.060.070.080.090.110.180.240.27

Financials of Cupid Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +4461848185160143133159172183391
Expenses +3236505365108107109118121141241
Operating Profit1325342721523623415142150
OPM %29%41%41%34%24%33%25%17%26%30%23%38%
Other Income +1211235457190
Interest000001101223
Depreciation222222333345
Profit before tax1125322621533825425355142
Tax %33%36%37%34%27%24%24%30%25%24%25%24%
Net Profit +816211715402917324041108
EPS in Rs0.060.120.150.130.110.300.220.130.240.300.300.81
Dividend Payout %22%21%22%29%35%15%21%35%21%0%0%0%

Financials of Cupid Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital1111111113131313131327134
Reserves132543556390118129154288315316
Borrowings +2102231096121956
Other Liabilities +814910153022231671146
Total Liabilities3551637893165152174189320372553
Fixed Assets +161616162126293136586767
CWIP0000031600625
Investments00518222148546914710375
Other Assets +1935424450114748483114196386
Total Assets3551637893165152174189320372553

Financials of Cupid Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +71320318194210338-1146
Cash from Investing Activity +-1-1-5-9-14-37-9-13-22-804528
Cash from Financing Activity +-3-6-4-3-516-333-1199-135
Net Cash Flow3611-9-0-20-1-02732110
Free Cash Flow61117112838230-17-3121
CFO/OP69%76%94%50%119%60%142%83%106%41%5%52%

Financials of Cupid Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days677959100979565845910213494
Inventory Days15560133259168437230197229184450173
Days Payable84278016213557916813410511375
Cash Conversion Cycle139112112198130-46127147183285570191
Working Capital Days58776713010840878777123210108
ROCE %48%79%72%43%29%50%28%17%26%22%17%33%

Others in Personal Products this season

  • Anondita Medicare Ltd (Q4 FY26)

    Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…

  • Gillette India Ltd (Q4 FY23)

    FY21/22 sales growth was -7% year-on-year (Page 5). Key concall takeaways from Gillette India Ltd's Q4 FY23 earnings call — and how it ranks against sector…

  • Procter & Gamble Hygiene and Health Care Ltd (Q3 FY19)

    The presentation reports sales of approximately INR 2,500 Crore (Page 16). Key concall takeaways from Procter & Gamble Hygiene and Health Care Ltd's Q3 FY19…

  • Honasa Consumer Ltd (Q2 FY26)

    Quick commerce channel is rapidly growing, currently about 10% of revenues, with healthy economics and fastest-growing channel. Key concall takeaways from…

Compare:vs Godrej Consumervs Dabur Indiavs Colgate-Palmoliv